Clinical Trial: Oral CBD Treatment Ineffective in Arthritic Patients

Aalborg, Denmark: The consumption of artificial CBD isn’t related to clinically vital reductions in ache depth in sufferers with both hand osteoarthritis or psoriatic arthritis, based on clinical trial data printed within the journal Ache.

Dutch investigators evaluated the efficacy of the every day use of artificial CBD versus placebo for 12 weeks in 129 sufferers with arthritis. Topics within the research consumed CBD (or placebo) as an adjunct to their commonly prescribed drugs. 

“We discovered neither clinically nor statistically vital impact of CBD for ache depth in sufferers with hand osteoarthritis and psoriatic arthritis when in comparison with placebo,” authors reported. “Moreover, no statistically vital results have been discovered on sleep high quality, melancholy, nervousness, or ache catastrophizing scores.”

Sufferers with arthritis usually report utilizing hashish therapeutically. Nevertheless, comparatively few managed research can be found assessing using both hashish or cannabinoids in sufferers with RA and the outcomes of those trials have been inconsistent. 

Full textual content of the research, “Cannabidiol therapy in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind placebo-controlled trial,” seems in Ache. Further info relating to using cannabinoids for arthritis is offered from NORML.